These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 205971)

  • 1. Platelet aggregation and cyclic nucleotide phosphodiesterase activity in arteriosclerotic patients.
    Yamazaki H; Motomiya T; Mashimo N; Asano T; Hidaka H
    Thromb Haemost; 1978 Feb; 39(1):158-66. PubMed ID: 205971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic nucleotide phosphodiesterase activities of the human liver: comparison between control and Reye's syndrome samples.
    Kang ES
    Pediatr Res; 1978 Jul; 12(7):761-6. PubMed ID: 211480
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M; Endo T; Kanayama T; Hidaka H
    J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
    Strada SJ; Thompson WJ
    Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cyclic nucleotide metabolism in the blood platelets and its relationship to the vascular wall].
    Yamazaki H
    Rinsho Byori; 1979; Suppl 40():40-6. PubMed ID: 233106
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
    Barber AJ
    Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ; Maurice DH
    Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
    Matsuoka I; Suzuki T
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of platelet sensitivity to ADP-aggregation by isometric exercise in arteriosclerosis patients and its prevention.
    Sano T; Motomiya T; Yamazaki H; Shimamoto T
    Thromb Haemost; 1977 Apr; 37(2):329-38. PubMed ID: 195363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotide phosphodiesterase activity in normal mice and mice with retinal degeneration.
    Robb RM
    Invest Ophthalmol Vis Sci; 1979 Oct; 18(10):1097-100. PubMed ID: 225287
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
    Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
    Simpson AW; Reeves ML; Rink TJ
    Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
    Hashimoto S; Shibata S; Kobayashi B
    Thromb Haemost; 1978 Feb; 39(1):177-85. PubMed ID: 205972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of cyclic nucleotide phosphodiesterase activity within the bovine photoreceptor cell.
    Pannbacker RG; Lovett K
    Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):166-8. PubMed ID: 188779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.